CompletedNCT00148083
Long-acting risperidone with social skills training for schizophrenia
About this title
Read the official source — NCT00148083Medication studyAges 18–55United States
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- Chicago and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateSeptember 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 5
- Sponsor
- University of Illinois Chicago
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00148083
- Official title
Show the full official title
Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago · White Plains
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Illinois Chicago, a university.
Did this study involve medication?
Yes. The study involved medication, including Risperdal Consta (drug).
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
